Most lately, it has been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar parts as classical opioid receptors, it binds to a big selection of endogenous opioids. Unlike most opioid receptors, this receptor acts being a scavenger https://fredb823ync3.qodsblog.com/profile